Hokkaido Venture Capital

Hokkaido Venture Capital is a corporate venture capital firm established in 1999 and headquartered in Sapporo, Japan. The firm specializes in providing investment opportunities to companies primarily within the technology sector. Hokkaido Venture Capital focuses on a range of investment stages, including seed, early, and later stages. Its investment interests encompass various industries, such as business products and services, healthcare, information technology, life sciences, the Internet of Things, manufacturing, and technology, media, and telecommunications (TMT). Through its strategic investments, Hokkaido Venture Capital aims to foster innovation and growth in the companies it supports.

Yoshinori Urata

President

26 past transactions

Sagri

Series A in 2024
Sagri, Inc. is a company based in Tamba, Japan, that specializes in developing agriculture software for experienced farmers. Founded in 2016, Sagri focuses on creating a data platform that addresses agricultural challenges through the use of satellite data and machine learning. This innovative platform enables users to analyze the status of agricultural land in their regions, collaborating with local governments and financial institutions. By providing digital mapping of abandoned cultivated land, Sagri aids agricultural committees in reducing the burden of land investigations and enhancing overall agricultural management.

Alyaum

Seed Round in 2024
Alyawmu provides solutions for hometown tax payment NFTs and tourism NFTs, leveraging blockchain technology to enhance community engagement. The company works with local governments and communities to integrate NFTs into Japan's Furusato Nozei system, offering digital assets as rewards for donations. Alyawmu also explores NFTs to promote local tourism and regional revitalization initiatives.

Letara

Seed Round in 2023
Letara operates a space technology platform intended to service a logistics network spanning the solar system. The company develops propulsion systems for small spacecraft, including high-thrust, plastic-based propulsion designed to be safe and inexpensive for research, development, and operational use in both Earth orbit and deep space, enabling small satellites and related assets to move efficiently across space.

AIQ

Series B in 2020
AIQ Corporation, established in 2017 and headquartered in Tokyo, Japan, specializes in developing an online platform that focuses on the planning, development, and sales of artificial intelligence and software technologies. The company's platform is designed to visualize and analyze market insights using profiling AI, helping to identify potential customers with high lifetime value (LTV). Additionally, AIQ offers services such as customer satisfaction surveys and investigates customer attributes in research and development, as well as marketing fields.

AIQ

Series B in 2020
AIQ aims to transform the way offline content is being consumed by bridging O2O (offline to online) media properties with its latest cutting-edge Computer Vision AI Technology where multiple platforms and channels can be integrated, allowing seamless interaction between online & offline content. AIQ's Video & Visual Recognition Technology empowers consumers with the ability to interact with their favourite brand’s & products, any where, any time. At AIQ, we redefine the way brands engage with customers because, we can.

Goryo Chemical

Venture Round in 2019
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

Interstellar Technologies

Series B in 2019
Interstellar Technologies Inc. is a Japanese company engaged in the development, manufacturing, and launch of sub-orbital rockets for space observations and zero-gravity experiments. Founded in 2003 and based in Hiroo-gun, Japan, it has successfully conducted three spaceflights with its MOMO rocket, becoming the first private entity in Japan to reach space. The company operates launch facilities in Taiki, Hokkaido, including Launch Complex-0 for the MOMO rocket and plans for Launch Complex-1 for its forthcoming ZERO rocket. Interstellar Technologies aims to make space more accessible through cost-effective and convenient transportation solutions, providing vertically integrated rocket and satellite development services. The company is expanding its facilities to support more frequent launches and accommodate larger vehicles, with the goal of enhancing the efficiency and cost-effectiveness of satellite deployment in the space industry.

Kamui Pharma

Venture Round in 2018
Kamui Pharma, Inc. is a drug discovery startup affiliated with Asahikawa Medical University, specializing in probiotic medicine. The company has developed a drug discovery platform aimed at creating innovative probiotic treatments, particularly for inflammatory bowel disease. Utilizing long-chain polyphosphoric acid derived from probiotics, Kamui Pharma's approach seeks to enhance therapeutic outcomes for patients suffering from this condition, thereby contributing to improved healthcare solutions.

Interstellar Technologies

Seed Round in 2017
Interstellar Technologies Inc. is a Japanese company engaged in the development, manufacturing, and launch of sub-orbital rockets for space observations and zero-gravity experiments. Founded in 2003 and based in Hiroo-gun, Japan, it has successfully conducted three spaceflights with its MOMO rocket, becoming the first private entity in Japan to reach space. The company operates launch facilities in Taiki, Hokkaido, including Launch Complex-0 for the MOMO rocket and plans for Launch Complex-1 for its forthcoming ZERO rocket. Interstellar Technologies aims to make space more accessible through cost-effective and convenient transportation solutions, providing vertically integrated rocket and satellite development services. The company is expanding its facilities to support more frequent launches and accommodate larger vehicles, with the goal of enhancing the efficiency and cost-effectiveness of satellite deployment in the space industry.

Goryo Chemical

Venture Round in 2016
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

Hamure

Venture Round in 2016
Hamure is a retail chain focused on providing work clothes and supplies. The company operates both online and physical stores, offering a diverse range of products that cater to various industries. Its inventory includes essential work goods such as gardening tools, safety shoes, and a wide assortment of clothing designed for use in demanding environments. By emphasizing quality and practicality, Hamure aims to meet the needs of customers who require reliable and durable work-related items.

Premium Hokkaido

Venture Round in 2016
Premium Hokkaido specializes in high-end travel services for affluent overseas visitors to Hokkaido, Japan. The company offers personalized itineraries, interpreter assistance, concierge services, and real estate advisory.

Fibergate Japan

Venture Round in 2016
Fibergate Inc. is an independent communication services provider based in Tokyo, Japan. Founded in 2000, the company specializes in various Wi-Fi solutions, including the construction and operation of free Wi-Fi hotspots for foreigners, buses, events, and tenants. It also offers hotel Wi-Fi implementation services and corporate network solutions, such as Internet VPN services and IPv6 migration solutions. Additionally, Fibergate develops, manufactures, and sells communication equipment like Wi-Fi routers, while also engaging in the Internet advertising business and the resale of mobile lines.

Mikage Bio Energy

Venture Round in 2016
Mikage Bio Energy is a Business Intelligence start up.

Medicinal Chemistry Pharmaceutical

Venture Round in 2015
Medicinal Chemistry Pharmaceuticals, Co., Ltd., founded in 2010 and headquartered in Sapporo, Japan, specializes in drug discovery and development services. The company is focused on creating innovative antibody drugs that leverage advanced glycotechnology to control various diseases. It offers high-quality glycopeptides as disease-specific starting materials to aid in the development of antibodies for cancer immunotherapy and other therapeutic applications. The firm's drug discovery capabilities include a comprehensive antibody-drug discovery system that integrates both the synthesis and analysis of sugar chain-related substances. Additionally, it provides a wide range of biochemical experiments aimed at capturing cancer cells, thereby supporting medical research and contributing to improved healthcare outcomes. Through its specialized technologies, Medicinal Chemistry Pharmaceuticals aims to enhance the therapeutic landscape for a variety of diseases.

Atmark Techno

Venture Round in 2015
Atmark Techno, Inc. is a manufacturer based in Sapporo, Japan, specializing in embedded computer hardware devices and software products. Founded in 1997, the company focuses on designing and developing low-power, high-performance small form factor CPU boards and embedded device platforms that integrate FPGA and Linux for network applications. Its product lineup includes Linux-ready ARM9 CPU boards and P2P Internet radio terminals. Atmark Techno also offers the Armadillo series, which supports Internet of Things (IoT) applications tailored for industrial environments, and provides device operation management services through its "node-eye" platform. The company's products are available through online shops and a network of distributors in Japan, Germany, and other international markets.

Hirakawa Winery

Venture Round in 2015
Hirakawa Winery is a producer and supplier of wine. They provide products that include serene, notre siècle, dawn, prestance, eloges, praise, and duality. They offer products that are available for shopping online.

EVEC

Venture Round in 2015
EVEC, Inc. is a biotechnology company based in Sapporo, Japan, founded in 2003. The company specializes in developing fully human antibodies derived from human peripheral blood lymphocytes, focusing on applications in treating diseases such as Clostridium difficile and human Metapneumovirus. Its innovative platform enables the safe and effective production of antibodies that can address challenging medical conditions, ultimately allowing for the development of less burdensome therapies and enhanced diagnostic tools. EVEC licenses its antibody products to pharmaceutical companies worldwide, contributing to advancements in medical treatments and diagnostics.

NIKKOKU SEIFUN

Venture Round in 2015
NIKKOKU SEIFUN is a manufacturer and seller of foods made from buckwheat and wheat.

INDETAIL

Venture Round in 2014
INDETAIL is a Japan-based technology company that develops smartphone applications, web systems, social games, UI/UX design, and e-commerce platforms, with operations in Sapporo, and it maintains a growing team of mainly Japanese staff alongside an international blockchain team to pursue practical blockchain adoption through collaborative projects and research that support business use cases. The company works on smart-city initiatives such as traffic infrastructure using electric vehicles and renewable energy, a multilingual smart check-in service for hotels connected to LINE, blockchain-based IoT solutions, and a medicines dead stock reselling service to enable transparent transactions between pharmacies, while also offering blockchain and AI expertise, data-driven solutions, consulting, UI/UX design, and cloud technology to help local ventures address regional challenges and create new opportunities.

Ecomott

Venture Round in 2011
Ecomott Inc. is a Japanese company that specializes in Internet of Things (IoT) and machine-to-machine (M2M) solutions. Established in 2007 and headquartered in Sapporo, Ecomott offers a range of innovative products, including FASTIO, an IoT platform; Yurimott, a remote supervision system for snow-melting; Gembaroid, a computerized construction support tool; and Pdrive, a solution aimed at traffic accident avoidance. The company's offerings cater to various sectors, encompassing network design, cloud application development, system integration, and device design and production. Ecomott is committed to addressing pressing social issues such as environmental challenges and the implications of an aging population, striving to leverage mobile Internet solutions to create a positive impact and become an essential player in societal advancements.

Gene Techno Science

Venture Round in 2010
Founded in 2001, Gene Techno Science is a Japanese biopharmaceutical company dedicated to researching and developing innovative drugs. Its portfolio includes treatments for immunological, cardiovascular, ophthalmic, infectious, renal diseases, and oncology.

Gene Techno Science

Venture Round in 2008
Founded in 2001, Gene Techno Science is a Japanese biopharmaceutical company dedicated to researching and developing innovative drugs. Its portfolio includes treatments for immunological, cardiovascular, ophthalmic, infectious, renal diseases, and oncology.

Tacere Therapeutics

Seed Round in 2006
Tacere Therapeutics, Inc. focuses on creating innovative therapeutics for serious infectious diseases, with a primary emphasis on Hepatitis C (HCV). The company leverages its expertise in RNA interference (RNAi), gene medicine, and advanced biologicals to identify and develop effective RNAi-based treatments. Tacere Therapeutics is dedicated to addressing critical health challenges through its proprietary capabilities in therapeutic development.

Berg Earth

Venture Round in 2005
Berg Earth Co Ltd is a Japan-based agribusiness company specializing in the production and sale of vegetable seedlings. The company primarily focuses on grafted seedlings of various fruits and vegetables, catering to the agricultural needs of its clientele. In addition to its seedling offerings, Berg Earth engages in the purchase and sale of agricultural products and materials, contributing to the broader agricultural supply chain. Its diverse product range includes various types of seedlings designed to meet different farming requirements.

B-Bridge International

Venture Round in 2005
B-Bridge International, Inc. is a biotechnology company that develops and distributes a wide range of cellular and molecular biology research tools for various sectors, including academia, government, pharmaceuticals, and biotechnology. Founded in 2000 and headquartered in Mountain View, California, with a subsidiary in Tokyo, Japan, the company offers an extensive portfolio of products such as antibodies, assay kits, reagents, and enzymes for diverse research applications, including cancer, immunology, and neurobiology. In addition to its product offerings, B-Bridge provides an online portal for technological innovations and application software for neuro-sensing products. The company also engages in consulting services related to deal brokerage, licensing, and technology transfer, facilitating connections between businesses in the U.S. and Japan. Through its international network of distributors and partners, B-Bridge aims to enhance the global presence of Japanese biotechnology and foster cross-cultural collaboration in research and development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.